Cutaneous leishmaniasis (CL) is a public health problem on a global level because it affects the population of 88 countries. In Morocco, it is widely distributed, caused by Leishmania tropica, Leishmania major and Leishmania infantum rarely. The geographical distribution of different forms of leishmaniasis in Morocco is linked to well described bioclimatic zones. Over the past two decades, the epidemiological situation of CL has changed significantly. It acquire an increasingly epidemic status with geographic expansion to previously free areas and the emergence of overlapping foci of cutaneous leishmaniasis and visceral leishmaniasis in several provinces of Morocco. In this review the evolution of the epidemiological situation and epidemiological factors which influenced the course of it in the past two decades will be reported. (Turkiye Parazitol Derg 2014; 38: 5-8)
Schistosomiasis is an endemic parasitic infection very linked to poverty. It is considered a world health problem since it infects people from 76 different countries especially tropical and subtropical regions. For many years, Morocco was endemic for shistosome infection. The unique form is urinary schistosomiasis and the first case was described in 1914. After an alarming prevalence rate (13 416 cases) in 1973, Morocco decided to establish a strategy to control and then to eliminate schistosomiasis through three major phases (control, elimination and consolidation). Since 2004 and until now, it isn't reported any new indigenous case. Morocco achieves the goal and succeeds in decreasing the prevalence of infection to a level of zero so eliminating schistosomiasis in all endemic geographic areas.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.